Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Tularik Inc. (TLRK) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (241)	6/19/2002 4:58:31 PM
From: Czechsinthemail	Read Replies (1) \| Respond to of 598

>>The slowest of the slow, handing off to those who will be regarded with awe.<< As Fernando (Billy Crystal) used to say: "You know, it's more important to look good than to feel good. And you know who you are." <g> If you are interested in timing, we just filled a gap in the NASDAQ from Friday's close to Monday's open. finance.yahoo.com^IXIC&d=c&k=c1&a=v&p=s&t=5d&l=on&z=l&q=l The silver lining view is that, with the market having filled it and closed without dropping significantly lower, it may be ready to move up. In any case, I'm impressed that biotechs have been improving their relative performance recently. I think there is a good chance that will continue through the July earnings season. Biotechs should have fewer problems from negative earnings surprises, plus earnings announcements provide opportunities to get positive news out. Biotechs are also less vulnerable to disruption by possible terrorist activity or to slower than expected general economic growth. That, and there is the snapback potential from being heavily oversold.